In chemically induced hepatocellular carcinoma mice, it has been found that sirt2 was induced in the immune microenvironment of hepatoma cells to enhance the tumor-killing activity of NK cells by promoting mitogen-activated protein kinase (MAPK) in activated NK cells (Chen M. et al., 2019). This evidence concerns the gene SIRT2 and hepatocellular carcinoma.